Furthermore, through the regulation of NRF2, MDSC, an immunosuppressive cell present in the CCA microenvironment, was reprogrammed into a phenotype that promotes the anti‐tumor function of CTLs via activation of the STING pathway. The gene discussed is NFE2L2; the disease is cholangiocarcinoma.